Two Sigma Advisers’s Athenahealth, Inc. ATHN Stock Holding History

Two Sigma Advisers’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,648	Closed	-$745K	–	2517
2018 Q4	$745K	Buy	5,648 +1,200	+27%	+$154K	﹤0.01%	1618
2018 Q3	$594K	Buy	4,448 +2,700	+154%	+$405K	﹤0.01%	1728
2018 Q2	$278K	Sell	1,748 -2,100	-55%	-$311K	﹤0.01%	2119
2018 Q1	$550K	Sell	3,848 -15,600	-80%	-$2.13M	﹤0.01%	1777
2017 Q4	$2.59M	Buy	+19,448	New	+$2.49M	0.01%	1126
2017 Q2	–	Sell	-121,048	Closed	-$13.6M	–	2480
2017 Q1	$13.6M	Sell	121,048 -31,300	-21%	-$3.65M	0.04%	474
2016 Q4	$16M	Buy	+152,348	New	+$16.4M	0.06%	345
2014 Q4	–	Sell	-2,848	Closed	-$358K	–	2920
2014 Q3	$375K	Buy	+2,848	New	+$375K	﹤0.01%	1720

Two Sigma Advisers's ATHN Position: Q1 2019 in Review

Two Sigma Advisers sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 5,648 shares — an estimated $745K sold.

Two Sigma Advisers first reported a position in ATHN in Q3 2014 and held it in 8 quarters. The position peaked at $16M in Q4 2016. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Two Sigma Advisers reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Two Sigma Advisers sold 5,648 Athenahealth, Inc. shares in Q1 2019, an estimated $745K.
Two Sigma Advisers first reported a position in Athenahealth, Inc. in Q3 2014 and held it in 8 quarters.
Two Sigma Advisers's Athenahealth, Inc. position peaked at $16M in Q4 2016.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Two Sigma Advisers's 13F filing for Q1 2019, filed 15 May 2019.